{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:09:59Z","timestamp":1776272999526,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["Grant No. LQ20H020012"],"award-info":[{"award-number":["Grant No. LQ20H020012"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["Grant No. LTGY23H270004"],"award-info":[{"award-number":["Grant No. LTGY23H270004"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["Grant No. LTGY23H290001"],"award-info":[{"award-number":["Grant No. LTGY23H290001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99010-y","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T07:17:45Z","timestamp":1745479065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Causal association between endocrine diseases and lymphoid malignancies explored through two-sample Mendelian randomization analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Chenze","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"99010_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.path.2021.06.001","volume":"14","author":"AD Ware","year":"2021","unstructured":"Ware, A. D., Davis, K. & Xian, R. R. Molecular pathology of mature lymphoid malignancies. Surg. Pathol. Clin. 14, 529\u2013547. https:\/\/doi.org\/10.1016\/j.path.2021.06.001 (2021).","journal-title":"Surg. Pathol. Clin."},{"key":"99010_CR2","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.4103\/jfmpc.jfmpc_1037_19","volume":"9","author":"R Singh","year":"2020","unstructured":"Singh, R. et al. Non-Hodgkin\u2019s lymphoma: A review. J. Family Med. Prim. Care. 9, 1834\u20131840. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1037_19 (2020).","journal-title":"J. Family Med. Prim. Care"},{"key":"99010_CR3","doi-asserted-by":"publisher","first-page":"e31944","DOI":"10.7759\/cureus.31944","volume":"14","author":"ZA Khan","year":"2022","unstructured":"Khan, Z. A. et al. The diagnostic dilemma of Splenic Non-Hodgkin\u2019s lymphoma and Splenic abscess: A narrative review. Cureus 14, e31944. https:\/\/doi.org\/10.7759\/cureus.31944 (2022).","journal-title":"Cureus"},{"key":"99010_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2174\/1389557523666230915103121","volume":"24","author":"S Liu","year":"2024","unstructured":"Liu, S., Xu, M., Zhong, L., Tong, X. & Qian, S. Recent advances in nanobiotechnology for the treatment of Non-Hodgkin\u2019s lymphoma. Mini Rev. Med. Chem. 24, 895\u2013907. https:\/\/doi.org\/10.2174\/1389557523666230915103121 (2024).","journal-title":"Mini Rev. Med. Chem."},{"key":"99010_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn, L. H., Salles, G., Diffuse Large, B-C. & Lymphoma N Engl. J. Med. 384, 842\u2013858, doi:https:\/\/doi.org\/10.1056\/NEJMra2027612 (2021).","journal-title":"N Engl. J. Med."},{"key":"99010_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3205","author":"KM Linton","year":"2023","unstructured":"Linton, K. M. et al. Personalised therapy in follicular lymphoma - is the dial turning? Hematol. Oncol. https:\/\/doi.org\/10.1002\/hon.3205 (2023).","journal-title":"Hematol. Oncol."},{"key":"99010_CR7","doi-asserted-by":"publisher","first-page":"100992","DOI":"10.1016\/j.blre.2022.100992","volume":"57","author":"MJ Gordon","year":"2023","unstructured":"Gordon, M. J., Smith, M. R. & Nastoupil, L. J. Follicular lymphoma: The long and winding road leading to your cure? Blood Rev. 57, 100992. https:\/\/doi.org\/10.1016\/j.blre.2022.100992 (2023).","journal-title":"Blood Rev."},{"key":"99010_CR8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41571-019-0239-8","volume":"16","author":"F Bosch","year":"2019","unstructured":"Bosch, F. & Dalla-Favera, R. Chronic lymphocytic leukaemia: From genetics to treatment. Nat. Rev. Clin. Oncol. 16, 684\u2013701. https:\/\/doi.org\/10.1038\/s41571-019-0239-8 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99010_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00281-018-0696-7","volume":"41","author":"U Klausen","year":"2018","unstructured":"Klausen, U., J\u00f8rgensen, N. G. D., Grauslund, J. H., Holmstr\u00f6m, M. O. & Andersen, M. H. Cancer immune therapy for lymphoid malignancies: Recent advances. Semin. Immunopathol. 41, 111\u2013124. https:\/\/doi.org\/10.1007\/s00281-018-0696-7 (2018).","journal-title":"Semin. Immunopathol."},{"key":"99010_CR10","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3324\/haematol.2016.149252","volume":"101","author":"WBC Stevens","year":"2016","unstructured":"Stevens, W. B. C., Netea, M. G., Kater, A. P. & van der Velden, W. J. F. M. \u2018Trained immunity: consequences for lymphoid malignancies. Haematologica 101, 1460\u20131468. https:\/\/doi.org\/10.3324\/haematol.2016.149252 (2016).","journal-title":"Haematologica"},{"key":"99010_CR11","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1158\/1055-9965.Epi-23-0565","volume":"32","author":"G Maskarinec","year":"2023","unstructured":"Maskarinec, G. et al. Association of obesity and type 2 diabetes with Non-Hodgkin lymphoma: the multiethnic cohort. Cancer Epidemiol. Biomarkers Prev. 32, 1348\u20131355. https:\/\/doi.org\/10.1158\/1055-9965.Epi-23-0565 (2023).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"99010_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.diabet.2019.04.006","volume":"46","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Association between type 1 and type 2 diabetes and risk of non-Hodgkin\u2019s lymphoma: A meta-analysis of cohort studies. Diabetes Metab. 46, 8\u201319. https:\/\/doi.org\/10.1016\/j.diabet.2019.04.006 (2020).","journal-title":"Diabetes Metab."},{"key":"99010_CR13","doi-asserted-by":"publisher","first-page":"e70327","DOI":"10.1002\/cam4.70327","volume":"13","author":"X Shi","year":"2024","unstructured":"Shi, X., Wallach, J. D., Ma, X. & Rogne, T. Autoimmune diseases and risk of Non-Hodgkin lymphoma: A Mendelian randomisation study. Cancer Med. 13, e70327. https:\/\/doi.org\/10.1002\/cam4.70327 (2024).","journal-title":"Cancer Med."},{"key":"99010_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60565-7","author":"J Drozd-Sokolowska","year":"2020","unstructured":"Drozd-Sokolowska, J. et al. Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP \u2013 the PLRG report. Sci. Rep.  https:\/\/doi.org\/10.1038\/s41598-020-60565-7 (2020).","journal-title":"Sci.Rep."},{"key":"99010_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041302","author":"E Birney","year":"2021","unstructured":"Birney, E. Mendelian randomization. Cold Spring Harbor Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a041302 (2021).","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"99010_CR16","first-page":"4270","volume":"16","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Genetically predicted telomere length and the risk of 11 hematological diseases: a Mendelian randomization study. Aging (Albany NY). 16, 4270\u20134281 (2024).","journal-title":"Aging (Albany NY)"},{"key":"99010_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518. https:\/\/doi.org\/10.1038\/s41586-022-05473-8 (2023).","journal-title":"Nature"},{"key":"99010_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal Pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7 (2018).","journal-title":"Nat. Genet."},{"key":"99010_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18236","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization. Jama  https:\/\/doi.org\/10.1001\/jama.2021.18236 (2021).","journal-title":"Jama"},{"key":"99010_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"MJA Brion","year":"2013","unstructured":"Brion, M. J. A., Shakhbazov, K. & Visscher, P. M. Calculating statistical power in Mendelian randomization studies. Int. J. Epidemiol. 42, 1497\u20131501. https:\/\/doi.org\/10.1093\/ije\/dyt179 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"99010_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng, J. et al. Recent developments in Mendelian randomization studies. Curr. Epidemiol. Rep. 4, 330\u2013345. https:\/\/doi.org\/10.1007\/s40471-017-0128-6 (2017).","journal-title":"Curr. Epidemiol. Rep."},{"key":"99010_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden, J. & Holmes, M. V. Meta-analysis and Mendelian randomization: A review. Res. Synthesis Methods. 10, 486\u2013496. https:\/\/doi.org\/10.1002\/jrsm.1346 (2019).","journal-title":"Res. Synthesis Methods"},{"key":"99010_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13870-3","author":"V Zuber","year":"2020","unstructured":"Zuber, V., Colijn, J. M., Klaver, C. & Burgess, S. Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization. Nat. Commun.  https:\/\/doi.org\/10.1038\/s41467-019-13870-3 (2020).","journal-title":"Nat.Commun."},{"key":"99010_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965 (2016).","journal-title":"Genet. Epidemiol."},{"key":"99010_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cll.2021.04.003","volume":"41","author":"DC Luca","year":"2021","unstructured":"Luca, D. C. Update on lymphoblastic leukemia\/lymphoma. Clin. Lab. Med. 41, 405\u2013416. https:\/\/doi.org\/10.1016\/j.cll.2021.04.003 (2021).","journal-title":"Clin. Lab. Med."},{"key":"99010_CR26","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard, F. & Mohty, M. Acute lymphoblastic leukaemia. Lancet 395, 1146\u20131162 (2020).","journal-title":"Lancet"},{"key":"99010_CR27","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba, H. & Mullighan, C. G. Pediatric acute lymphoblastic leukemia. Haematologica 105, 2524\u20132539. https:\/\/doi.org\/10.3324\/haematol.2020.247031 (2020).","journal-title":"Haematologica"},{"key":"99010_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/17474086.2020.1685866","volume":"13","author":"M Bloom","year":"2019","unstructured":"Bloom, M., Maciaszek, J. L., Clark, M. E., Pui, C. H. & Nichols, K. E. Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia. Expert Rev. Hematol. 13, 55\u201370. https:\/\/doi.org\/10.1080\/17474086.2020.1685866 (2019).","journal-title":"Expert Rev. Hematol."},{"key":"99010_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1586\/17474086.2015.978281","volume":"8","author":"F Ceppi","year":"2014","unstructured":"Ceppi, F., Cazzaniga, G., Colombini, A., Biondi, A. & Conter, V. Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention. Expert Rev. Hematol. 8, 57\u201370. https:\/\/doi.org\/10.1586\/17474086.2015.978281 (2014).","journal-title":"Expert Rev. Hematol."},{"key":"99010_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cnur.2017.07.006","volume":"52","author":"MR Ortiz","year":"2017","unstructured":"Ortiz, M. R. Hypoglycemia in diabetes. Nurs. Clin. North Am. 52, 565\u2013574. https:\/\/doi.org\/10.1016\/j.cnur.2017.07.006 (2017).","journal-title":"Nurs. Clin. North Am."},{"key":"99010_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ecl.2021.05.013","volume":"50","author":"MG Tinajero","year":"2021","unstructured":"Tinajero, M. G. & Malik, V. S. An update on the epidemiology of type 2 diabetes. Endocrinol. Metab. Clin. North Am. 50, 337\u2013355. https:\/\/doi.org\/10.1016\/j.ecl.2021.05.013 (2021).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"99010_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s2213-8587(18)30315-2","volume":"7","author":"SA Amiel","year":"2019","unstructured":"Amiel, S. A. et al. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: Epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 7, 385\u2013396. https:\/\/doi.org\/10.1016\/s2213-8587(18)30315-2 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"99010_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/dia.2012.0181","volume":"15","author":"N Visavachaipan","year":"2013","unstructured":"Visavachaipan, N., Aledo, A., Franklin, B. H. & Brar, P. C. Continuous glucose monitoring: A valuable monitoring tool for management of hypoglycemia during chemotherapy for acute lymphoblastic leukemia. Diabetes. Technol. Ther. 15, 97\u2013100. https:\/\/doi.org\/10.1089\/dia.2012.0181 (2013).","journal-title":"Diabetes. Technol. Ther."},{"key":"99010_CR34","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3109\/10428194.2011.580024","volume":"52","author":"J Trelinska","year":"2011","unstructured":"Trelinska, J. et al. Hypoglycemia and glycemic variability among children with acute lymphoblastic leukemia during maintenance therapy. Leuk. Lymphoma. 52, 1704\u20131710. https:\/\/doi.org\/10.3109\/10428194.2011.580024 (2011).","journal-title":"Leuk. Lymphoma"},{"key":"99010_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1110523","author":"R Xu","year":"2023","unstructured":"Xu, R., Zheng, T., Ouyang, C., Ding, X. & Ge, C. Causal associations between site-specific cancer and diabetes risk: A two-sample Mendelian randomization study. Front. Endocrinol.  https:\/\/doi.org\/10.3389\/fendo.2023.1110523 (2023).","journal-title":"Front.Endocrinol."},{"key":"99010_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-0998-0","author":"B Bielorai","year":"2018","unstructured":"Bielorai, B. & Pinhas-Hamiel, O. Type 2 diabetes mellitus, the metabolic syndrome, and its components in adult survivors of acute lymphoblastic leukemia and hematopoietic stem cell transplantations. Curr. Diab. Rep.  https:\/\/doi.org\/10.1007\/s11892-018-0998-0 (2018).","journal-title":"Curr. Diab.Rep."},{"key":"99010_CR37","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1210\/jc.2018-01168","volume":"104","author":"A Iqbal","year":"2019","unstructured":"Iqbal, A. et al. Effect of hypoglycemia on inflammatory responses and the response to Low-Dose endotoxemia in humans. J. Clin. Endocrinol. Metabolism. 104, 1187\u20131199. https:\/\/doi.org\/10.1210\/jc.2018-01168 (2019).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"99010_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051825","author":"F Arruga","year":"2020","unstructured":"Arruga, F. et al. Immune response dysfunction in chronic lymphocytic leukemia: dissecting molecular mechanisms and microenvironmental conditions. Int. J. Mol. Sci.  https:\/\/doi.org\/10.3390\/ijms21051825 (2020).","journal-title":"Int. J. Mol.Sci."},{"key":"99010_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41574-021-00510-4","volume":"17","author":"J Yong","year":"2021","unstructured":"Yong, J., Johnson, J. D., Arvan, P., Han, J. & Kaufman, R. J. Therapeutic opportunities for pancreatic \u03b2-cell ER stress in diabetes mellitus. Nat. Reviews Endocrinol. 17, 455\u2013467. https:\/\/doi.org\/10.1038\/s41574-021-00510-4 (2021).","journal-title":"Nat. Reviews Endocrinol."},{"key":"99010_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01041-4","author":"M Packer","year":"2020","unstructured":"Packer, M. Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs. Cardiovasc. Diabetol.  https:\/\/doi.org\/10.1186\/s12933-020-01041-4 (2020).","journal-title":"Cardiovasc.Diabetol."},{"key":"99010_CR41","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.immuni.2022.11.001","volume":"55","author":"E Masle-Farquhar","year":"2022","unstructured":"Masle-Farquhar, E. et al. STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2Dhi CD8\u2009+\u2009T cell dysregulation and accumulation. Immunity 55, 2386\u20132404e2388. https:\/\/doi.org\/10.1016\/j.immuni.2022.11.001 (2022).","journal-title":"Immunity"},{"key":"99010_CR42","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1002\/cncr.31538","volume":"124","author":"BL Andersen","year":"2018","unstructured":"Andersen, B. L. et al. Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemia. Cancer 124, 3240\u20133248. https:\/\/doi.org\/10.1002\/cncr.31538 (2018).","journal-title":"Cancer"},{"key":"99010_CR43","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/s41416-024-02594-x","volume":"130","author":"R Abrah\u00e3o","year":"2024","unstructured":"Abrah\u00e3o, R. et al. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study. Br. J. Cancer. 130, 1166\u20131175. https:\/\/doi.org\/10.1038\/s41416-024-02594-x (2024).","journal-title":"Br. J. Cancer"},{"key":"99010_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/aje\/kwn160","volume":"168","author":"C Chao","year":"2008","unstructured":"Chao, C. & Page, J. H. Type 2 diabetes mellitus and risk of Non-Hodgkin lymphoma: A systematic review and Meta-Analysis. Am. J. Epidemiol. 168, 471\u2013480. https:\/\/doi.org\/10.1093\/aje\/kwn160 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"99010_CR45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/08880018.2020.1713940","volume":"37","author":"A Rebelo","year":"2020","unstructured":"Rebelo, A., Oliveira, J. & Sousa, C. Severe mercaptopurine-induced hypoglycemia in acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 37, 245\u2013247. https:\/\/doi.org\/10.1080\/08880018.2020.1713940 (2020).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"99010_CR46","doi-asserted-by":"publisher","first-page":"1301093","DOI":"10.3389\/fendo.2023.1301093","volume":"14","author":"X Xie","year":"2023","unstructured":"Xie, X. et al. Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review. Front. Endocrinol. (Lausanne). 14, 1301093. https:\/\/doi.org\/10.3389\/fendo.2023.1301093 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"99010_CR47","doi-asserted-by":"publisher","first-page":"630160","DOI":"10.3389\/fmed.2021.630160","volume":"8","author":"JL Jiang","year":"2021","unstructured":"Jiang, J. L. et al. Post-transplantation cyclophosphamide, tacrolimus and Low-Dose ATG as GVHD prophylaxis for allogeneic peripheral stem cell transplantation for adult patients with lymphoid malignancies: A single arm phase II study. Front. Med. (Lausanne). 8, 630160. https:\/\/doi.org\/10.3389\/fmed.2021.630160 (2021).","journal-title":"Front. Med. (Lausanne)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99010-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99010-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99010-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T17:02:56Z","timestamp":1745859776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99010-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99010"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99010-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14231"}}